chr7-116499858-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001233.5(CAV2):āc.77A>Cā(p.Glu26Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,610,174 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001233.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAV2 | NM_001233.5 | c.77A>C | p.Glu26Ala | missense_variant | 1/3 | ENST00000222693.5 | NP_001224.1 | |
CAV2 | NM_001206747.2 | c.38A>C | p.Glu13Ala | missense_variant | 1/3 | NP_001193676.1 | ||
CAV2 | NM_198212.3 | c.77A>C | p.Glu26Ala | missense_variant | 1/2 | NP_937855.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAV2 | ENST00000222693.5 | c.77A>C | p.Glu26Ala | missense_variant | 1/3 | 1 | NM_001233.5 | ENSP00000222693 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151618Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000416 AC: 1AN: 240394Hom.: 0 AF XY: 0.00000763 AC XY: 1AN XY: 131104
GnomAD4 exome AF: 0.00000823 AC: 12AN: 1458556Hom.: 1 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 725364
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151618Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74042
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.77A>C (p.E26A) alteration is located in exon 1 (coding exon 1) of the CAV2 gene. This alteration results from a A to C substitution at nucleotide position 77, causing the glutamic acid (E) at amino acid position 26 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at